13-110205476-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.903+18G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.631 in 1,612,206 control chromosomes in the GnomAD database, including 325,047 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 26219 hom., cov: 32)
Exomes 𝑓: 0.64 ( 298828 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.61

Publications

15 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 13-110205476-C-T is Benign according to our data. Variant chr13-110205476-C-T is described in ClinVar as Benign. ClinVar VariationId is 258266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.742 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001845.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
NM_001845.6
MANE Select
c.903+18G>A
intron
N/ANP_001836.3P02462-1
COL4A1
NM_001303110.2
c.903+18G>A
intron
N/ANP_001290039.1P02462-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
ENST00000375820.10
TSL:1 MANE Select
c.903+18G>A
intron
N/AENSP00000364979.4P02462-1
COL4A1
ENST00000543140.6
TSL:1
c.903+18G>A
intron
N/AENSP00000443348.1P02462-2
COL4A1
ENST00000650424.2
c.903+18G>A
intron
N/AENSP00000497477.2A0A3B3ISV3

Frequencies

GnomAD3 genomes
AF:
0.577
AC:
87124
AN:
151054
Hom.:
26222
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.426
Gnomad AMI
AF:
0.796
Gnomad AMR
AF:
0.544
Gnomad ASJ
AF:
0.700
Gnomad EAS
AF:
0.763
Gnomad SAS
AF:
0.690
Gnomad FIN
AF:
0.605
Gnomad MID
AF:
0.630
Gnomad NFE
AF:
0.636
Gnomad OTH
AF:
0.620
GnomAD2 exomes
AF:
0.619
AC:
155701
AN:
251374
AF XY:
0.630
show subpopulations
Gnomad AFR exome
AF:
0.423
Gnomad AMR exome
AF:
0.497
Gnomad ASJ exome
AF:
0.702
Gnomad EAS exome
AF:
0.762
Gnomad FIN exome
AF:
0.602
Gnomad NFE exome
AF:
0.640
Gnomad OTH exome
AF:
0.639
GnomAD4 exome
AF:
0.637
AC:
930058
AN:
1461036
Hom.:
298828
Cov.:
51
AF XY:
0.639
AC XY:
464541
AN XY:
726856
show subpopulations
African (AFR)
AF:
0.410
AC:
13567
AN:
33102
American (AMR)
AF:
0.500
AC:
22337
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.704
AC:
18410
AN:
26134
East Asian (EAS)
AF:
0.774
AC:
30741
AN:
39698
South Asian (SAS)
AF:
0.674
AC:
58125
AN:
86254
European-Finnish (FIN)
AF:
0.603
AC:
32189
AN:
53418
Middle Eastern (MID)
AF:
0.658
AC:
3792
AN:
5764
European-Non Finnish (NFE)
AF:
0.641
AC:
712400
AN:
1111628
Other (OTH)
AF:
0.638
AC:
38497
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
19892
39784
59676
79568
99460
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18804
37608
56412
75216
94020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.576
AC:
87137
AN:
151170
Hom.:
26219
Cov.:
32
AF XY:
0.578
AC XY:
42736
AN XY:
73926
show subpopulations
African (AFR)
AF:
0.426
AC:
17304
AN:
40610
American (AMR)
AF:
0.543
AC:
8294
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.700
AC:
2429
AN:
3470
East Asian (EAS)
AF:
0.762
AC:
3940
AN:
5170
South Asian (SAS)
AF:
0.690
AC:
3328
AN:
4820
European-Finnish (FIN)
AF:
0.605
AC:
6396
AN:
10568
Middle Eastern (MID)
AF:
0.619
AC:
182
AN:
294
European-Non Finnish (NFE)
AF:
0.636
AC:
43247
AN:
67966
Other (OTH)
AF:
0.616
AC:
1294
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1817
3634
5452
7269
9086
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.618
Hom.:
82924
Bravo
AF:
0.564
Asia WGS
AF:
0.684
AC:
2379
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
2
not provided (2)
-
-
1
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome (1)
-
-
1
Brain small vessel disease 1 with or without ocular anomalies (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.13
DANN
Benign
0.38
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs482757; hg19: chr13-110857823; COSMIC: COSV104687933; API